An initial appraisal of the value of serum carbohydrate antigenic determinant (CA 19-9) levels in patients with pancreatic cancer
- 1 January 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (1) , 87-91
- https://doi.org/10.1016/0277-5379(87)90424-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondariesClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bankInternational Journal of Cancer, 1984
- Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.Clinical Chemistry, 1983
- A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.Journal of Biological Chemistry, 1982
- The diagnosis of “early” pancreatic cancer: The university of Chicago experienceCancer, 1981
- Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancerThe American Journal of Surgery, 1980
- Colorectal carcinoma antigens detected by hybridoma antibodiesSomatic Cell and Molecular Genetics, 1979
- Isoamylases in Pancreatic Carcinoma and Chronic Relapsing PancreatitisScandinavian Journal of Gastroenterology, 1977